ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993

Univ. Of Pittsburgh Plans Molecular Medicine Institute.

January 25, 2002

Genentech’s Ferrara Selected for GM Award.

June 23, 2006

NAB Approves Subcommittee Recommendations On Organ Site Program – NIH Review, One Headquarters

May 21, 1982

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.

January 23, 2004